- Home
- BHVN vs RLX Comparison
BHVN vs RLX Comparison
Compare BHVN & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHVN | RLX |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BHVN | RLX |
|---|---|---|
| Price | $14.03 | $1.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | ★ $21.27 | $2.77 |
| AVG Volume (30 Days) | ★ 2.5M | 1.2M |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | ★ 6.71% |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $62.88 |
| Revenue Next Year | N/A | $23.93 |
| P/E Ratio | ★ N/A | $28.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.48 | $1.64 |
| 52 Week High | $18.57 | $2.60 |
Technical Indicators
Market Signals| Indicator | BHVN | RLX |
|---|---|---|
| Relative Strength Index (RSI) | 58.41 | 28.11 |
| Support Level | $13.56 | N/A |
| Resistance Level | $15.27 | $1.75 |
| Average True Range (ATR) | 0.81 | 0.04 |
| MACD | 0.32 | -0.00 |
| Stochastic Oscillator | 56.59 | 10.71 |
Price Performance
Historical ComparisonAbout BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market. The company has two reportable segments, Core Markets and Europe Acquisition. The majority of the revenue is earn from Core Markets segment.